Health, Medicine and Natural Healing 11

179,008 topics in this forum

1. Ofatumumab for newly diagnosed and relapsed/refractory CLL

   By Guest guest, March 2, 2011
   • 0 replies
   • 25 views
   • 
   • Guest
   • March 2, 2011

2. Interleukin-21 and rituximab enhance NK cell functionality in patients with B-cell chronic lymphocytic leukaemia.

   By Guest guest, March 2, 2011
   • 0 replies
   • 31 views
   • 
   • Guest
   • March 2, 2011

3. Confused about what's in ACA?

   By Guest guest, March 6, 2011
   • 0 replies
   • 26 views
   • 
   • Guest
   • March 6, 2011

4. Researchers Predict Age of T Cells to Improve Cancer Treatment

   By Guest guest, March 7, 2011
   • 0 replies
   • 20 views
   • 
   • Guest
   • March 7, 2011

5. Researchers Discover How Cancer Cheats Immune System

   By Guest guest, March 9, 2011
   • 0 replies
   • 19 views
   • 
   • Guest
   • March 9, 2011

6. Combinin lenalidomide with CAL101

   By Guest guest, March 10, 2011
   • 0 replies
   • 20 views
   • 
   • Guest
   • March 10, 2011

7. Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients

   By Guest guest, March 10, 2011
   • 0 replies
   • 36 views
   • 
   • Guest
   • March 10, 2011

8. Prospective study of clinical and biological prognostic factors at diagnosis in patients with early stage B-cell chronic lymphocytic leukemia

   By Guest guest, February 24, 2011
   • 0 replies
   • 27 views
   • 
   • Guest
   • February 24, 2011

9. Biologic agent activity in chronic lymphocytic leukemia: a framework for future therapies

   By Guest guest, February 24, 2011
   • 0 replies
   • 33 views
   • 
   • Guest
   • February 24, 2011

10. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia

    By Guest guest, February 24, 2011
    • 0 replies
    • 39 views
    • 
    • Guest
    • February 24, 2011

11. relapsed CLL/SLL - study of interest: FCR+btk-inhib. v. BR+btk-inhib.

    By Guest guest, February 18, 2011
    • 0 replies
    • 27 views
    • 
    • Guest
    • February 18, 2011

12. Analysis of CLLU1 expression levels before and after therapy in patients with Chronic Lymphocytic Leukemia

    By Guest guest, February 24, 2011
    • 0 replies
    • 37 views
    • 
    • Guest
    • February 24, 2011

13. Carson to leave as UCSD Cancer Director; Kipps will be interim Director

    By Guest guest, February 19, 2011
    • 0 replies
    • 26 views
    • 
    • Guest
    • February 19, 2011

14. Lenalidomide + Rituxan for Pts w/CD5+ lymphoma/CLL

    By Guest guest, February 19, 2011
    • 0 replies
    • 17 views
    • 
    • Guest
    • February 19, 2011

15. Easily find studies by subtype and treatment status

    By Guest guest, February 20, 2011
    • 0 replies
    • 24 views
    • 
    • Guest
    • February 20, 2011

16. Personalizing treatment for chronic lymphocytic leukemia

    By Guest guest, February 24, 2011
    • 0 replies
    • 31 views
    • 
    • Guest
    • February 24, 2011

17. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab

    By Guest guest, February 24, 2011
    • 0 replies
    • 65 views
    • 
    • Guest
    • February 24, 2011

18. media report on acadesine for CLL

    By Guest guest, February 21, 2011
    • 0 replies
    • 30 views
    • 
    • Guest
    • February 21, 2011

19. Chronic Lymphocytic Leukemia (CLL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

    By Guest guest, February 22, 2011
    • 0 replies
    • 26 views
    • 
    • Guest
    • February 22, 2011

20. SUPPORT GROUP in Sacramento, CA

    By Guest guest, August 13, 2011
    • 0 replies
    • 23 views
    • 
    • Guest
    • August 13, 2011

21. What's New Preview: important new items

    By Guest guest, August 13, 2011
    • 0 replies
    • 32 views
    • 
    • Guest
    • August 13, 2011

22. You will read much on this encouraging news

    By Guest guest, August 12, 2011
    • 0 replies
    • 30 views
    • 
    • Guest
    • August 12, 2011

23. U Penn research results, awesome!

    By Guest guest, August 11, 2011
    • 1 reply
    • 21 views
    • 
    • Guest
    • August 11, 2011

24. phase I ... addressing sub-therapeutic doses

    By Guest guest, August 7, 2011
    • 0 replies
    • 25 views
    • 
    • Guest
    • August 7, 2011

25. Lymphomation: What's New Digest - Aug 6, 2011

    By Guest guest, August 6, 2011
    • 0 replies
    • 39 views
    • 
    • Guest
    • August 6, 2011